293
Views
11
CrossRef citations to date
0
Altmetric
Review

Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus

, &
Pages 507-513 | Published online: 30 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anand Swaroop, Manashi Bagchi, Pawan Kumar, Harry G. Preuss & Debasis Bagchi. (2015) Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats. Toxicology Mechanisms and Methods 25:9, pages 653-664.
Read now

Articles from other publishers (10)

Hesham Salem, Amany Abdelaziz, Mariam Galal, Maha Hussien, Nadeen Emad, Asmaa E. Batekh, Mohamed Karem & Deena A. Moukhtar. (2023) Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 299, pages 122838.
Crossref
Ahmed H. Abdelazim & Sherif Ramzy. (2022) Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules. BMC Chemistry 16:1.
Crossref
Wisuwat Thongphichai, Tamonwan Uttarawichien, Pithi Chanvorachote, Supaporn Pitiporn, Todsaphol Charoen-ame, Pakakrong Kwankhao, Pasarapa Towiwat & Suchada Sukrong. (2022) Standardization of the ethanolic extract of Crinum latifolium leaves by two bioactive markers with antiproliferative activity against TGF-β-promoted prostate stromal cells (WPMY-1). BMC Complementary Medicine and Therapies 22:1.
Crossref
David-Dan Nguyen, Quoc-Dien Trinh & Naeem Bhojani. (2022) Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade. European Urology 81:4, pages 323-324.
Crossref
Hyekyung Ha, Seong Eun Jin, Chang-Seob Seo & Hyeun-kyoo Shin. (2021) Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san. Journal of Korean Medicine 42:4, pages 10-24.
Crossref
Robert E. Pyke. (2019) Toward a Scientific Nutritional Supplement Combination for Prostatism and Erectile Dysfunction I: From Known Pharmacology to Clinical Testing. Journal of Medicinal Food 22:5, pages 529-537.
Crossref
Nagaraju Pappula, Balaji Kodali & Peda Varma Datla. (2018) Selective and rapid determination of tadalafil and finasteride using solid phase extraction by high performance liquid chromatography and tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 152, pages 215-223.
Crossref
A. Alcántara Montero. (2017) Comment to “Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence”. Actas Urológicas Españolas (English Edition) 41:7, pages 435-436.
Crossref
A. Alcántara Montero. (2017) Comentario editorial a «Hiperplasia prostática benigna y síntomas del tracto urinario inferior. Revisión de las evidencias actuales». Actas Urológicas Españolas 41:7, pages 435-436.
Crossref
Chris Olesovsky & Anil Kapoor. (2016) Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia. Therapeutic Advances in Urology 8:4, pages 257-271.
Crossref